Related Experiment Video
Updated: Jun 25, 2026

Investigating Migraine-Like Behavior Using Light Aversion in Mice
Published on: August 11, 2021
Calcitonin-Gene-Related Peptide in Migraine and Tension-Type Headache in Children During Interictal Period
Jadranka Sekelj Fures1,2, Vlasta Duranovic1, Jasna Lenicek Krleza3,4,5
1Department of Pediatric Neurology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
Insights
Elevated serum calcitonin-gene-related peptide (CGRP) levels indicate pediatric migraine, differing by migraine type and age of onset. This finding clarifies CGRP
Area of Science:
- Neurology
- Pediatrics
- Biochemistry
Background:
- Calcitonin-gene-related peptide (CGRP) is extensively studied in adult migraine, but its role in childhood migraine is less understood.
- Pediatric headache disorders, including migraine and tension-type headache (TTH), significantly impact children's quality of life.
Purpose of the Study:
- To investigate serum CGRP levels in children with migraine and TTH during interictal periods.
- To compare CGRP levels between pediatric migraine patients, TTH patients, and healthy controls.
- To explore the influence of migraine type (with aura vs. without aura) and age of onset on CGRP levels.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used to quantify serum CGRP levels.
- Participants included 66 migraine patients, 59 TTH patients, and 53 age-matched healthy controls.
- Patients were stratified by headache onset age: under 7, 7-12, and over 12 years.
Main Results:
- Migraine patients exhibited significantly higher serum CGRP levels compared to TTH patients and controls (p < 0.001).
- No significant difference in CGRP levels was observed between TTH patients and controls.
- Migraine without aura (MO) patients showed higher CGRP levels than migraine with aura (MA) patients. In preadolescent MA patients (onset 7-12 years), CGRP levels were lower than in MO patients.
Conclusions:
- Elevated serum CGRP is a potential biomarker for pediatric migraine.
- CGRP levels in pediatric migraine vary based on migraine phenotype and age of onset.
- Findings suggest distinct pathophysiological mechanisms in pediatric migraine subtypes, particularly concerning CGRP involvement in preadolescence.
Abstract:
Background/Objectives: Research on calcitonin-gene-related peptide (CGRP) in adult migraine is extensive, but its role in childhood migraine remains unclear. This study aimed to evaluate serum CGRP levels in children experiencing migraine and tension-type headache (TTH) during interictal periods, comparing these levels to age-matched healthy controls. Methods: A total of 66 migraine patients, 59 with TTH, and 53 controls were recruited and stratified by headache onset age: under 7, 7-12, and over 12 years. CGRP levels were quantified using enzyme-linked immunosorbent assay (ELISA). Results: The migraine patients showed significantly higher serum CGRP levels than both the TTH patients and the controls (p < 0.001), with no significant difference between the latter two groups. Among the migraine patients, those without aura (MO) exhibited higher CGRP levels than those with aura (MA). The CGRP levels were lower in the. MA patients whose headaches began between ages 7 and 12 compared to the subjects with MO, while no significant differences were found in the patients whose headaches began after age 12. Conclusions: These findings suggest that elevated serum CGRP is indicative of pediatric migraine, with variations based on migraine type and age of onset. The difference in CGRP in preadolescent migraineurs with and without aura suggest that CGRP levels may vary depending on age and on migraine type.
More Related Videos
08:39Ex Vivo Release of Calcitonin Gene-Related Peptide from the Trigeminovascular System in Rodents
Published on: May 16, 2022
07:14Detection and Quantification of Calcitonin Gene-Related Peptide CGRP in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay
Published on: June 16, 2023
Related Concept Videos
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology